Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure
- 3 January 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (2) , A41-A45
- https://doi.org/10.1016/0002-9149(89)90392-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- II. Protagonist's viewpointJournal of the American College of Cardiology, 1988
- I. IntroductionJournal of the American College of Cardiology, 1988
- Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.Circulation, 1987
- A double-blind dose response comparison of oral enoximone and placebo for congestive heart failureThe American Journal of Cardiology, 1987
- Withdrawal of long-term amrinone therapy in patients with congestive heart failure: a placebo controlled trialEuropean Heart Journal, 1986
- Milrinone in the treatment of chronic cardiac failure: A controlled trialAmerican Heart Journal, 1985
- Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.Circulation, 1985
- Oral amrinone for the treatment of chronic congestive heart failure: Results of a multicenter randomized double-blind and placebo-controlled withdrawal studyJournal of the American College of Cardiology, 1984
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- The role of cyclic AMP in isoprenaline-induced cardiac necroses in the ratJournal of Pharmacy and Pharmacology, 1971